Cart
Colon Cancer Diagnostic Tests Market - Global Opportunity Analysis and Industry Forecast, 2019-2026
|
LI_184867
|
Pages: NA
|
Jul 2019 |
298 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4 COLON CANCER DIAGNOSTIC TESTS MARKET, BY TEST
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. FECAL OCCULT BLOOD TESTS (FOBT)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Guaiac FOB stool test
4.2.4.1. Market size and forecast
4.2.5. Immuno-FOB ELISA test
4.2.5.1. Market size and forecast
4.3. BIOMARKER TESTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. DNA based biomarkers test
4.3.4.1. Market size and forecast
4.3.5. Protein based biomarkers test
4.3.5.1. Market size and forecast
4.3.6. Metabolite based biomarkers test
4.3.6.1. Market size and forecast
CHAPTER 5 COLON CANCER DIAGNOSTIC TESTS MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast
5.3. CLINICAL DIAGNOSTIC LABORATORIES
5.3.1. Market size and forecast
5.4. PHYSICIANS’ OFFICE LABORATORIES
5.4.1. Market size and forecast
5.5. HOME TEST KIT
5.5.1. Market size and forecast
CHAPTER 6 COLON CANCER DIAGNOSTIC TESTS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. North America Colon Cancer Diagnostic Tests Market by Country
6.2.3.1. U.S.
6.2.3.1.1. U.S. Colon Cancer Diagnostic Tests Market by Test
6.2.3.1.2. U.S. Colon Cancer Diagnostic Tests Market by End User
6.2.3.2. Canada
6.2.3.2.1. Canada Colon Cancer Diagnostic Tests Market by Test
6.2.3.2.2. Canada Colon Cancer Diagnostic Tests Market by End User
6.2.3.3. Mexico
6.2.3.3.1. Mexico Colon Cancer Diagnostic Tests Market by Test
6.2.3.3.2. Mexico Colon Cancer Diagnostic Tests Market by End User
6.2.4. North America Colon Cancer Diagnostic Tests Market by Test
6.2.5. North America Colon Cancer Diagnostic Tests Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Europe Colon Cancer Diagnostic Tests Market by Country
6.3.3.1. Germany
6.3.3.1.1. Germany Colon Cancer Diagnostic Tests Market by Test
6.3.3.1.2. Germany Colon Cancer Diagnostic Tests Market by End User
6.3.3.2. France
6.3.3.2.1. France Colon Cancer Diagnostic Tests Market by Test
6.3.3.2.2. France Colon Cancer Diagnostic Tests Market by End User
6.3.3.3. UK
6.3.3.3.1. UK Colon Cancer Diagnostic Tests Market by Test
6.3.3.3.2. UK Colon Cancer Diagnostic Tests Market by End User
6.3.3.4. Italy
6.3.3.4.1. Italy Colon Cancer Diagnostic Tests Market by Test
6.3.3.4.2. Italy Colon Cancer Diagnostic Tests Market by End User
6.3.3.5. Spain
6.3.3.5.1. Spain Colon Cancer Diagnostic Tests Market by Test
6.3.3.5.2. Spain Colon Cancer Diagnostic Tests Market by End User
6.3.3.6. Rest of Europe
6.3.3.6.1. Rest of Europe Colon Cancer Diagnostic Tests Market by Test
6.3.3.6.2. Rest of Europe Colon Cancer Diagnostic Tests Market by End User
6.3.4. Europe Colon Cancer Diagnostic Tests Market by Test
6.3.5. Europe Colon Cancer Diagnostic Tests Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Asia-Pacific Colon Cancer Diagnostic Tests Market by Country
6.4.3.1. Japan
6.4.3.1.1. Japan Colon Cancer Diagnostic Tests Market by Test
6.4.3.1.2. Japan Colon Cancer Diagnostic Tests Market by End User
6.4.3.2. China
6.4.3.2.1. China Colon Cancer Diagnostic Tests Market by Test
6.4.3.2.2. China Colon Cancer Diagnostic Tests Market by End User
6.4.3.3. Australia
6.4.3.3.1. Australia Colon Cancer Diagnostic Tests Market by Test
6.4.3.3.2. Australia Colon Cancer Diagnostic Tests Market by End User
6.4.3.4. India
6.4.3.4.1. India Colon Cancer Diagnostic Tests Market by Test
6.4.3.4.2. India Colon Cancer Diagnostic Tests Market by End User
6.4.3.5. South Korea
6.4.3.5.1. South Korea Colon Cancer Diagnostic Tests Market by Test
6.4.3.5.2. South Korea Colon Cancer Diagnostic Tests Market by End User
6.4.3.6. Rest of Asia-Pacific
6.4.3.6.1. Rest of Asia-Pacific Colon Cancer Diagnostic Tests Market by Test
6.4.3.6.2. Rest of Asia-Pacific Colon Cancer Diagnostic Tests Market by End User
6.4.4. Asia-Pacific Colon Cancer Diagnostic Tests Market by Test
6.4.5. Asia-Pacific Colon Cancer Diagnostic Tests Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. LAMEA Colon Cancer Diagnostic Tests Market by Country
6.5.3.1. Brazil
6.5.3.1.1. Brazil Colon Cancer Diagnostic Tests Market by Test
6.5.3.1.2. Brazil Colon Cancer Diagnostic Tests Market by End User
6.5.3.2. Saudi Arabia
6.5.3.2.1. Saudi Arabia Colon Cancer Diagnostic Tests Market by Test
6.5.3.2.2. Saudi Arabia Colon Cancer Diagnostic Tests Market by End User
6.5.3.3. South Africa
6.5.3.3.1. South Africa Colon Cancer Diagnostic Tests Market by Test
6.5.3.3.2. South Africa Colon Cancer Diagnostic Tests Market by End User
6.5.3.4. Rest of LAMEA
6.5.3.4.1. Rest of LAMEA Colon Cancer Diagnostic Tests Market by Test
6.5.3.4.2. Rest of LAMEA Colon Cancer Diagnostic Tests Market by End User
6.5.4. LAMEA Colon Cancer Diagnostic Tests Market by Test
6.5.5. LAMEA Colon Cancer Diagnostic Tests Market by End User
CHAPTER 7 COMPANY PROFILES
7.1. QUIDEL CORPORATION
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. EIKEN CHEMICAL CO., LTD.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. EPIGENOMICS AG
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. BECKMAN COULTER, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ABBOTT LABORATORIES
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. BIOHIT OYJ.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. POLYMEDCO CDP, LLC
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. QUEST DIAGNOSTICS INCORPORATED
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. RANDOX LABORATORIES LTD.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. EDP BIOTECH
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Colon Cancer Diagnostic Tests Market- Global Opportunity Analysis and Industry Forecast, 2019-2026
- Online Only
-
$3456$3110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3840$3456 - Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5370$4833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6450$5805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8995$8096 - Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Buy Full Version
"Colon Cancer Diagnostic Tests Market"
Purchase Enquiry